Maternal smoking during pregnancy and multiple sclerosis amongst offspring

Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
European Journal of Neurology (Impact Factor: 4.06). 01/2009; 15(12):1395-9. DOI: 10.1111/j.1468-1331.2008.02331.x
Source: PubMed


An association between parental smoking and multiple sclerosis (MS) in offspring has been reported. This study examined whether maternal smoking during pregnancy is associated with MS in offspring.
Swedish general population registers provided prospectively recorded information on maternal smoking during pregnancy. The study identified 143 cases with MS diagnosed by 2006 and 1730 matched controls. Subjects were born since 1982 and individually matched by year of birth, age, sex and region of residence. Conditional logistic regression assessed the association of maternal smoking with MS in offspring with adjustment for socioeconomic index.
Maternal smoking during pregnancy was not associated with MS in offspring, with an odds ratio (and 95% confidence interval) of 0.96 (0.65-1.44). When stratified by paediatric or later MS onset there was no association with maternal smoking in either stratum.
It is unlikely that smoking during pregnancy represents a risk for early-onset MS amongst offspring.

Download full-text


Available from: Anders Ekbom, Oct 05, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper shows how the type 8560A metal ceramic tetrode can be used in a compact conduction cooled cavity at 470 MHz. This system offers significant advantages over more conventional fan cooled cavities or lumped circuit amplifiers.
    Vehicular Technology Conference, 1966. 17th IEEE; 01/1967
  • G Ebers ·
    [Show abstract] [Hide abstract]
    ABSTRACT: No abstract is available for this article.
    European Journal of Neurology 01/2009; 15(12):1263-4. DOI:10.1111/j.1468-1331.2008.02329.x · 4.06 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to estimate the influence of tobacco smoking and Swedish snuff use on the risk of developing multiple sclerosis (MS). A population-based case-control study was performed in Sweden, using incident cases of MS (902 cases and 1,855 controls). A case was defined as a subject from the study base who had received a diagnosis of MS, and controls were randomly selected from the study base. The incidence of MS among smokers was compared with that of never-smokers. We also investigated whether the use of Swedish snuff had an impact on the risk of developing MS. Smokers of both sexes had an increased risk of developing MS (odds ratio [OR] 1.4, 95% confidence interval [CI] 1.2-1.7 for women, and OR 1.8, 95% CI 1.3-2.5 for men). The increased risk was apparent even among subjects who had previously smoked moderately (< or =5 pack-years) prior to index, and the risk increased with increasing cumulative dose (p < 0.0001). The increased risk for MS associated with smoking remained up to 5 years after stopping smoking. In contrast, taking Swedish snuff for more than 15 years decreased the risk of developing MS (OR 0.3, 95% CI 0.1-0.8). Smokers of both sexes run an increased risk of developing multiple sclerosis (MS), and the risk increases with cumulative dose of smoking. However, the use of Swedish snuff is not associated with elevated risk for MS, which may indicate that nicotine is not the substance responsible for the increased risk of developing MS among smokers.
    Neurology 09/2009; 73(9):696-701. DOI:10.1212/WNL.0b013e3181b59c40 · 8.29 Impact Factor
Show more